Professional
Added to YB: 2024-11-14
Pitch date: 2024-11-13
TXG [neutral]
10x Genomics, Inc.
+28.53%
current return
Author Info
Pernas Research is a former CIO of a $3.5B fund that now share actionable stock research. Sign up for the newsletter.
Company Info
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific.
Market Cap
$2.3B
Pitch Price
$14.93
Price Target
N/A
Dividend
N/A
EV/EBITDA
-36.65
P/E
-51.91
EV/Sales
2.92
Sector
Life Sciences Tools and Services
Category
value
Pernas Research Passes On: 10x Genomics, Inc.
TXG pass: Leader in single-cell analysis (75-80% mkt share) w/ Chromium platform. High throughput, cost-effective. Concerns: single product reliance, market saturation, slowing growth. P/S 4x, cash burn. $1.9B mrkt cap, $15.68 price.
Read full article (1 min)